Back to results
CompletedPhase 3

An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease

NCT00814801

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

Fukuoka, Japan

View on ClinicalTrials.gov
An Efficacy and Safety Study of Galantamine for the Treatment of Patients With Alzheimer's Disease — TrialFind